GENE ONLINE|News &
Opinion
Blog

2021-06-18| ChinaPolicySpecial

From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships

by Daniel Ojeda
Share To
The US-China relationship is under a lot of stress following a trade war and a global pandemic. For companies, these are crucial markets that offer great opportunities but also great challenges.
During the BIO Digital 2021, a panel of policy experts discussed their opinions and views on how the US-China relationships will affect biotechnology companies in 2021. 

GO Prime with only $1.49 now

LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top